Physician profile
Stephen Augustine
NPI 1538120639
$12,516.42
in general payments reported to CMS, 2019-2025
21 companies · $496 in 2025
The $496 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.38 · 2020: $1,312 · 2021: $3,613 · 2022: $2,313 · 2023: $2,860 · 2024: $1,870 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,453 · Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,452.76 |
| Food and Beverage | $1,772.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $6,635.31 | 2021-2025 | |
| Arthrex, INC. | $3,384.12 | 2021-2025 | |
| Lima USA, INC. | $1,289.65 | 2020 | |
| Stryker Corporation | $362.19 | 2022-2024 | Mako, Triathlon |
| Amgen INC. | $148.85 | 2024-2025 | Evenity, Krystexxa |
| Depuy Synthes Sales INC. | $144.76 | 2024 | Dynacord, Expressew, Truespan Orthocord |
| Illuminoss Medical, INC. | $108.20 | 2022 | |
| Acacia Pharma INC | $77.23 | 2022 | |
| Access Pro Medical, LLC | $66.00 | 2022 | |
| Davol INC. | $48.29 | 2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Olympus America INC. | $36.13 | 2019 | |
| Baxter Healthcare | $23.72 | 2024 | Perclot |
| Sanara Medtech INC. | $23.45 | 2024 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $22.92 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $22.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bioventus LLC | $20.89 | 2023 | Exogen Ultrasound Bone Healing System |
| Becton, Dickinson and Company | $18.78 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.25 | 2019 | |
| Smith+Nephew, INC. | $11.44 | 2020 | |
| Integra Lifesciences Corporation | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.